Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Equity Ratio (2019 - 2025)

Historic Equity Ratio for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 0.22.

  • Eton Pharmaceuticals' Equity Ratio fell 5037.29% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 5037.29%. This contributed to the annual value of 0.32 for FY2024, which is 3419.0% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Equity Ratio of 0.22 as of Q3 2025, which was down 5037.29% from 0.24 recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Equity Ratio registered a high of 0.69 during Q2 2021, and its lowest value of 0.22 during Q3 2025.
  • Moreover, its 5-year median value for Equity Ratio was 0.52 (2022), whereas its average is 0.49.
  • Its Equity Ratio has fluctuated over the past 5 years, first surged by 38321.12% in 2021, then crashed by 5037.29% in 2025.
  • Eton Pharmaceuticals' Equity Ratio (Quarter) stood at 0.64 in 2021, then decreased by 18.6% to 0.52 in 2022, then dropped by 6.67% to 0.49 in 2023, then tumbled by 34.19% to 0.32 in 2024, then crashed by 31.04% to 0.22 in 2025.
  • Its Equity Ratio was 0.22 in Q3 2025, compared to 0.24 in Q2 2025 and 0.29 in Q1 2025.